真性红细胞增多症中的单核细胞增多:临床与分子相关性
在267例世界卫生组织(WHO)定义的真性红细胞增多症(PV)患者中,21%出现绝对单核细胞计数(AMC)≥1×10^9/L,7%出现AMC≥1.5×10^9/L。单核细胞增多的PV患者年龄更大,白细胞增多及TET2/SRSF2突变频率更高。AMC≥1.5×10^9/L在单变量分析中与较差的总生存(OS)和无骨髓纤维化生存(MFFS)相关,多变量分析中OS和MFFS的显著性为临界水平。
要点
- PV患者中单核细胞增多(AMC≥1×10^9/L)发生率为21%,AMC≥1.5×10^9/L为7%。
- 单核细胞增多的PV患者年龄更大,白细胞增多及TET2/SRSF2突变频率更高。
- AMC≥1.5×10^9/L在单变量分析中与较差的OS和MFFS相关,多变量分析中显著性为临界水平。
核心结论
- 本研究发现PV患者中单核细胞增多的患病率高于预期,且单核细胞增多PV患者的突变谱和年龄分布与慢性粒单核细胞白血病(CMML)患者相似,可能部分导致其预后较差。
研究设计与样本
- 研究纳入267例连续的世界卫生组织(WHO)定义的PV患者,分析单核细胞增多的患病率、实验室与分子相关性及预后意义。
主要发现
- 267例PV患者中,55例(21%)AMC≥1×10^9/L,18例(7%)AMC≥1.5×10^9/L。
- 单核细胞增多的PV患者显著年龄更大,白细胞增多频率更高(AMC≥1×10^9/L时81% vs 50%)。
- AMC≥1.5×10^9/L时TET2/SRSF2突变频率分别为57%/29%,而对照为19%/1%。
- 单变量分析中,AMC≥1.5×10^9/L对总生存(OS;P=0.004;HR 2.6,95%CI 1.4-4.8)和无骨髓纤维化生存(MFFS;P=0.02;HR 4.4,95%CI 1.3-15.1)有不良影响。
- 多变量分析中,OS(P=0.05)和MFFS(P=0.06)的显著性为临界水平。
关键数值与推荐
- OS的其他独立危险因素包括不良核型(P=0.02,HR 3.39,95%CI 1.17-9.79)、年龄较大(P<0.0001,HR 3.34,95%CI 1.97-5.65)和白细胞增多≥15×10^9/L(P=0.004,HR 2.04,95%CI 1.26-3.29)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Monocytosis (absolute monocyte count, AMC ≥ 1 × 109 /L) might accompany a spectrum of myeloid neoplasms, other than chronic myelomonocytic leukemia (CMML). In the current study, we examined the prevalence, laboratory and molecular correlates, and prognostic relevance of monocytosis in polycythemia vera (PV). Among 267 consecutive patients with World Health Organization (WHO)-defined PV, 55 (21%) patients displayed an AMC of ≥1 × 109 /L and 18 (7%) an AMC of ≥1.5 × 109 /L. In general, PV patients with monocytosis were significantly older and displayed higher frequencies of leukocytosis (81% vs. 50% at AMC ≥1 × 109 /L) and TET2/SRSF2 mutations (57%/29% vs. 19%/1% at AMC ≥ 1.5 × 109 /L). In univariate analysis, AMC ≥1.5 × 109 /L adversely affected overall (OS; P = .004; HR 2.6, 95% CI 1.4-4.8) and myelofibrosis-free (MFFS; P = .02; HR 4.4, 95% CI 1.3-15.1) survival; during multivariable analysis, significance was borderline sustained for OS (P = .05) and MFFS (P = .06). Other independent risk factors for OS included unfavorable karyotype (P = .02, HR 3.39, 95% CI 1.17-9.79), older age (P < .0001, HR 3.34 95% CI 1.97-5.65), and leukocytosis ≥15 × 109 /L (P = .004, HR 2.04, 95% CI 1.26-3.29). In conclusion, in the current study, we encountered a higher than expected prevalence of monocytosis in patients with PV and the mutation profile and age distribution of PV patients with monocytosis is akin to those of patients with CMML and might partly contribute to their worse prognosis.
引用
- Barraco D, Cerquozzi S, Gangat N, et al. Monocytosis in polycythemia vera: Clinical and molecular correlates. Am J Hematol. 2017. PMID: 28370365. doi:10.1002/ajh.24740
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。